(RTTNews) - AbbVie, Inc. (ABBV) and Neomorph, Inc. announced Thursday a collaboration and option-to-license agreement to develop novel molecular glue degraders for multiple targets across oncology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback